SARS-CoV-2mRNAOmicron

Ryuta Uraki1,2, Masaki Imai1,2, Mutsumi Ito1

  • 1Division of Virology, Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan.

NPJ vaccines
|January 3, 2024
PubMed
概括

新的基于脂质纳米粒子的mRNA疫苗针对SARS-CoV-2变种,如BA.5和XBB.1.5,显示出更好的疗效. 与祖先菌株相比,这些先进的疫苗提供了更好的保护,并减少了病毒载量.